EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+19.73%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$433M
AUM Growth
+$433M
(-0.52%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-8.42%
Top 10 Holdings %
Top 10 Hldgs %
72.23%
Holding
30
New
2
Increased
5
Reduced
11
Closed
3
Top Buys
| 1 |
Icon
ICLR
|
$23.9M |
| 2 |
Tandem Diabetes Care
TNDM
|
$17.7M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$14.8M |
| 4 |
Natera
NTRA
|
$8.8M |
| 5 |
4D Molecular Therapeutics
FDMT
|
$1.54M |
Top Sells
| 1 |
Humana
HUM
|
$28.7M |
| 2 |
AstraZeneca
AZN
|
$20.7M |
| 3 |
Illumina
ILMN
|
$15.2M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$7.79M |
| 5 |
American Well
AMWL
|
$6.33M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$32.4B
| $41.8M | 9.65% |
204,095
+4,200
| +2% | +$861K |
|
2
Alnylam Pharmaceuticals
ALNY
$58.5B
| $37M | 8.54% |
155,716
-6,000
| -4% | -$1.43M |
|
3
United Therapeutics
UTHR
$13.8B
| $36.5M | 8.42% |
131,238
-9,500
| -7% | -$2.64M |
|
|
4
Natera
NTRA
$23.1B
| $32.7M | 7.55% |
814,994
+219,000
| +37% | +$8.8M |
|
5
Outset Medical
OM
$247M
| $31.5M | 7.27% |
1,220,609
-17,381
| -1% | -$449K |
|
6
Intuitive Surgical
ISRG
$170B
| $28.7M | 6.63% |
108,230
-13,400
| -11% | -$3.56M |
|
|
7
Illumina
ILMN
$15.8B
| $27.9M | 6.43% |
137,914
-75,287
| -35% | -$15.2M |
|
|
8
Tandem Diabetes Care
TNDM
$845M
| $26.5M | 6.12% |
590,500
+394,100
| +201% | +$17.7M |
|
9
Inspire Medical Systems
INSP
$2.77B
| $25.6M | 5.9% |
101,543
+990
| +1% | +$249K |
|
10
DexCom
DXCM
$29.5B
| $24.8M | 5.72% |
219,000
-46,800
| -18% | -$5.3M |
|
|
11
Icon
ICLR
$13.8B
| $23.9M | 5.52% |
+123,100
| New | +$23.9M |
|
12
argenx
ARGX
$43.6B
| $22.8M | 5.27% |
60,300
| – | – |
|
|
SGEN
13
DELISTED
Seagen Inc. Common Stock
SGEN
| $22.5M | 5.19% |
174,902
| – | – |
|
|
CTLT
14
DELISTED
CATALENT, INC.
CTLT
| $14.8M | 3.42% |
+329,100
| New | +$14.8M |
|
|
15
4D Molecular Therapeutics
FDMT
$288M
| $9.73M | 2.24% |
437,911
+69,500
| +19% | +$1.54M |
|
16
Agios Pharmaceuticals
AGIO
$2.19B
| $7.52M | 1.73% |
267,630
-62,083
| -19% | -$1.74M |
|
17
Adaptive Biotechnologies
ADPT
$2.01B
| $4.64M | 1.07% |
607,860
-607,000
| -50% | -$4.64M |
|
|
18
American Well
AMWL
$111M
| $3.95M | 0.91% |
1,395,039
-2,236,671
| -62% | -$6.33M |
|
|
CMAX
19
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $2.61M | 0.6% |
714,755
| – | – |
|
20
Guardant Health
GH
$8.41B
| $1.81M | 0.42% |
66,560
-85,400
| -56% | -$2.32M |
|
21
10x Genomics
TXG
$1.74B
| $1.79M | 0.41% |
49,200
| – | – |
|
22
Beam Therapeutics
BEAM
$1.66B
| $1.13M | 0.26% |
28,900
| – | – |
|
|
OLK
23
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $1.02M | 0.23% |
40,000
| – | – |
|
24
Arvinas
ARVN
$568M
| $787K | 0.18% |
23,000
| – | – |
|
|
BCYC
25
Bicycle Therapeutics
BCYC
$511M
| $696K | 0.16% |
23,500
| – | – |
|